SHINE-HFNCT05583773
SHengXIaN-QuYu DEcoction in Heart Failure With Reduced and Mildly Reduced Ejection Fraction
At risk: Primary completion moved 1 year 7 months later.
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 13 versions: 13 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Aug 31, 2025 to Mar 31, 2027 Show 4 more changesShow less
- Eligibility criteria expanded, about 15 words
- Study completion pushed from Dec 31, 2025 to Dec 31, 2027
- Secondary endpoints: details revised at 5 of 9 entries
- Site details revised at 8 of 26 sites
Notable Eligibility criteria expanded, about 1 wordv12 Show 4 more changesShow less
- Study sites: 21 to 26
- Primary completion date: Apr 30, 2025 to Aug 31, 2025
- Study title revised
- Study description expanded, about 2 words
- Minor Study sites: 17 to 21v11
- Notable Enrollment target: 564 to 336v10
- Notable Eligibility criteria revised
- Interventions: Placebo (Other), Shengxian Quyu Decoction (Drug) to Placebo (Other), ShengXian-QuYu Decoction (Drug)
- Study description shortened, about 1 word
Show 7 earlier versionsHide 7 earlier versions
- Notable Enrollment target: 308 to 564
- Study sites: 4 to 17
- Study title shortened, about 1 word
- Notable Primary endpoint revised
- Study sites: 3 to 4
- Secondary endpoints revised (9)
- Minor Study sites: 2 to 3v6
- Minor Study sites: 1 to 2v5
- Notable Trial status: Not Yet Recruiting to Recruiting
- Study sites: 0 to 1
- Start date changed from estimate of Feb 7, 2023 to Mar 29, 2023
- Notable Start date: Dec 10, 2022 to Feb 7, 2023v3
- Notable Start date: Nov 1, 2022 to Dec 10, 2022v2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (8)
Show 3 moreShow less
Arms and interventions
Patients will be randomized 1:1 to either ShengXian-QuYu Decoction or placebo. "ShengXian-QuYu Decoction" (calculated by a medicine): 30g of Astragalus membranaceus (Huangqi), 12g of Cornus officinalis (Shanzhuyu), 9g of Panax ginseng (Hongshen), 12g of Anemarrhena asphodeloides (Zhimu), 8g of Cimicifuga foetida (Shengma), 8g of Bupleurum chinense (Chaihu), 10g of Platycodon grandiflorum (Jiegeng), 10g of Sparganium stoloniferum (Sanleng), 9g of Curcuma phaeocaulis (Ezhu), 3g of Whitmania pigra (Shuizhi).
Placebo matching ShengXian-QuYu Decoction
Drugs: ShengXian-QuYu Decoction
Other: Placebo
Sites
26 sites in 1 country